Market Access Manager, EU Center New Remote - Germany

BridgeBio Inc.; Germany; Remote; EUR 150,000 - 190,000; Full time

Benefits offered by this job

Market-leading compensation

Hybrid work model

Career development programs

Job summary

BridgeBio Inc. is seeking an experienced Market Access professional for Germany, reporting to the Senior Director, Market Access, EU Center.

You will own the German AMNOG process end to end, from the value dossier to price negotiations, and lead reimbursement submissions in Austria and Switzerland. You will collaborate with Medical Affairs, HEOR, Regulatory, Commercial and cross‑functional teams to secure patient access across the DACH region, translating payer insights into regional access

Qualifications

• Degree in health economics, pharmacy, medicine, life sciences or comparable field.
• 5–8 years of market access or HTA experience in pharma, consultancy or HTA service provider.
• Experience preparing AMNOG value dossiers under § 35a SGB V and reimbursement price negotiations under § 130b SGB V.
• Solid command of G-BA and IQWiG methodology with payer-ready argumentation.
• Experience engaging payers and hospitals on reimbursement; knowledge of German hospital financing; Austria/Switzerland a plus.
• Business-fluent German and English.
• Willingness to travel ~20% of working time.

Responsibilities

• Lead AMNOG value dossiers end to end: plan, resource, quality‑assure and submit dossiers under § 35a SGB V to G-BA.
• Own G-BA and IQWiG interactions: prepare requests, run procedures, manage timelines.
• Prepare and support price negotiations: develop pricing strategy and scenarios for § 130b negotiations.
• Drive regional payer engagement with sickness funds, Medical Service and regional physician groups; translate insights into regional concepts.
• Secure hospital and clinic reimbursement: advise on NUB, DRG, pricing and formulary processes.
• Resolve access barriers and turn issues into training material with Medical Affairs.
• Extend access beyond Germany: lead submissions in Austria and Switzerland.

Skills

German

English

HTA experience

ORAL/PID communication

Education

Degree in health economics, pharmacy, medicine, life sciences or comparable field

Job description

When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allowsscience and small teams of experts to lead the way. We build bridges to groundbreaking advancements in raredisease, anddevelop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we’llask"why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.

What You’ll Do

You will report to the Senior Director, Market Access, EU Center and work closely with Medical Affairs, HEOR, Regulatory, Commercial and our global Market Access team to secure and sustain patient access to BridgeBio’s medicines across the DACH region. Your remit is to own the German AMNOG process end to end – from the value dossier under § 35a SGB V through the reimbursement price negotiation with the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) under § 130b SGB V – and regional market access, which turns that outcome into real‑world access through direct engagement with sickness funds, the Medical Service, regional physicians’ associations, hospitals and treating centres. You will also lead reimbursement submissions in Austria and Switzerland. This role requires effective collaboration with cross‑functional colleagues and external stakeholders to ensure high‑quality execution and impact. The ideal candidate combines deep AMNOG and HTA expertise with strong communication skills, adaptability, and the ability to thrive in a fast‑paced, hands‑on environment.

Responsibilities

• Lead AMNOG value dossiers end to end: plan, resource, quality‑assure and submit complete dossiers under § 35a SGB V to the Federal Joint Committee (G-BA), including derivation of the appropriate comparator therapy (zVT), early identification of evidence gaps and defensible argumentation on indirect comparisons, surrogate and subgroup analyses
• Own G-BA and IQWiG interactions: prepare scientific advice requests under § 8 AM-NutzenV, run written commenting procedures and oral hearings, and manage all procedural communication and timelines
• Prepare and support price negotiations: develop pricing strategy, negotiation mandate, scenarios and European reference price analyses for the negotiation with the GKV-Spitzenverband under § 130b SGB V, and plan realistically for arbitration board risk
• Drive regional payer engagement: engage sickness funds at federal and regional level, the Medical Service (MD) and regional physicians’ associations (KVen) on reimbursement, cost‑efficiency reviews and prior‑authorisation practice, and translate those insights into regional access concepts
• Secure hospital and clinic reimbursement: advise treating centres on NUB applications, DRG and additional‑payment (ZE) mapping, budget and price negotiations, drug committees and formulary listing, including outpatient care via ASV under § 116b SGB V
• Resolve access barriers in the field: handle individual reimbursement requests, denials and claw‑backs together with Medical Affairs and the field teams, and turn recurring issues into argumentation aids and training material
• Extend access beyond Germany: lead reimbursement submissions in Austria (EKO) and Switzerland (FOPH Specialities List), and bring market access requirements into study design, evidence planning and launch planning across the cross‑functional team

Where You’ll Work

• This is a Germany-based remote role
• Approximately 20% travel is anticipated – for G-BA and GKV-Spitzenverband meetings in Berlin, regional payer and hospital meetings across Germany, selected meetings in Austria and Switzerland, and as‑needed visits to our International HQ in Zug

Who You Are

• Degree in health economics, pharmacy, medicine, life sciences or a comparable field
• 5–8 years of experience in market access or HTA – in the pharmaceutical industry, a consultancy or a specialised HTA service provider
• Demonstrated experience preparing AMNOG value dossiers under § 35a SGB V, ideally as project lead on at least one complete procedure, plus hands‑on involvement in a reimbursement price negotiation under § 130b SGB V
• Solid command of G-BA and IQWiG methodology, procedural rules and statutory timelines, with the ability to appraise clinical evidence critically and translate it into payer‑ready argumentation
• Experience engaging payers and/or hospitals directly on reimbursement matters, and the confidence to lead those conversations yourself; knowledge of German hospital financing (NUB, DRG, additional payments) and of reimbursement in Austria and Switzerland is a strong plus
• Strong written argumentation and the ability to work autonomously in an environment where some processes are still being built; experience with orphan drugs or a limited evidence base is an advantage
• Business‑fluent German and English
• Willingness to travel approximately 20% of working time

Rewarding Those Who Make the Mission Possible

We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.

• Market-leading compensation
• Hybrid work model – we value your flexibility in how you work, but encourage time in the office to strengthen our culture, collaboration, and sense of community
• We provide career development through regular feedback, continuous education and professional development programs
• We celebrate strong performance with financial rewards, peer‑to‑peer recognition, and growth opportunities.

As a global company, our comprehensive benefits may vary based on location. We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.

For BridgeBio Full-Time U.S Based Roles:

• Market-leading compensation
• 401(k) with employer match
• Employee Stock Purchase Program (ESPP)
• Pre-tax commuter benefits (transit and parking)
• Referral bonus for hired candidates
• Subsidized lunch and parking on in-office days
• 100% employer-paid medical, dental, and vision premiums for you and your dependents
• HealthSavings Account (HSA) with annual employer contributions, plus Flexible Spending Accounts (FSA)
• Fertility & family-forming benefits
• Expanded mental health support (therapy and coaching resources)
• Hybrid work model with flexibility
• Flexible, “take-what-you-need” paid time off and company-paid holidays
• Comprehensive paid medical and parental leave to care for yourself and your family

Skill Development & Career Paths:

• People are part of our growth and success story - from discovery to active drug trials and FDA pipelines, there are endless opportunities for skill development and internal mobility
• We provide career pathing through regular feedback, continuouseducationand professional development programs via LinkedIn Learning,LifeLabs, &BetterUpCoaching
• We celebratestrong performancewith financial rewards, peer‑to‑peer recognition, and growth opportunities